IMPLEMENTATION OF THE OMERACT PSAMRIS IN A PHASE IIB, RANDOMISED PLACEBO-CONTROLLED STUDY OF ABATACEPT IN PSORIATIC ARTHRITIS

被引:0
|
作者
Ostergaard, M. [1 ,2 ]
Bird, P. [3 ]
Pachai, C. [4 ]
Du, S. [4 ]
Wu, C. [5 ]
Landis, J. [5 ]
Fuerst, T. [6 ]
Ahmad, H. A. [7 ]
Connolly, S. [8 ]
Conaghan, P. G. [9 ]
机构
[1] Rigshosp, Copenhagen Ctr Arthrit Res, Ctr Rheumatol & Spine Dis, Glostrup, Denmark
[2] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[3] Univ New South Wales NSW, Div Med, Sydney, NSW, Australia
[4] Bristol Myers Squibb, Translat Med, Princeton, NJ USA
[5] Bristol Myers Squibb, Translat Bioinformat, Princeton, NJ USA
[6] BioClinica Inc, Med & Sci Affairs, Newark, CA USA
[7] Bristol Myers Squibb, Med Affairs Immunol & Fibrosis, Princeton, NJ USA
[8] Bristol Myers Squibb, Global Drug Dev, Princeton, NJ USA
[9] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
关键词
D O I
10.1136/annrheumdis-2021-eular.972
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
POS1040
引用
收藏
页码:794 / 794
页数:1
相关论文
共 50 条
  • [1] Implementation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Scoring System in a randomized phase IIb study of abatacept in psoriatic arthritis
    Ostergaard, Mikkel
    Bird, Paul
    Pachai, Chahin
    Du, Shuyan
    Wu, Chun
    Landis, Jessica
    Fuerst, Thomas
    Ahmad, Harris A.
    Connolly, Sean E.
    Conaghan, Philip G.
    RHEUMATOLOGY, 2022, 61 (11) : 4305 - 4313
  • [2] Validation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) for the Hand and Foot in a Randomized Placebo-controlled Trial
    Glinatsi, Daniel
    Bird, Paul
    Gandjbakhch, Frederique
    Mease, Philip J.
    Boyesen, Pernille
    Peterfy, Charles G.
    Conaghan, Philip G.
    Ostergaard, Mikkel
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (12) : 2473 - 2479
  • [3] Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis
    Mease, Philip J.
    Gottlieb, Alice B.
    van der Heijde, Desiree
    FitzGerald, Oliver
    Johnsen, Alyssa
    Nys, Marleen
    Banerjee, Subhashis
    Gladman, Dafna D.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (09) : 1550 - 1558
  • [4] ABATACEPT IN PSORIATIC ARTHRITIS: A SINGLE CENTRE, PLACEBO-CONTROLLED, CROSSOVER STUDY IN 20 PATIENTS; A PILOT PROTEOMIC FEASIBILITY STUDY
    Kwasnik, A.
    Pennington, S.
    FitzGerald, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1022 - 1022
  • [5] Ciprofloxacin DPI: a randomised, placebo-controlled, phase IIb efficacy and safety study on cystic fibrosis
    Dorkin, Henry L.
    Staab, Doris
    Operschall, Elisabeth
    Alder, Jeff
    Criollo, Margarita
    BMJ OPEN RESPIRATORY RESEARCH, 2015, 2 (01): : 1 - 10
  • [6] Sulphasalazine in psoriatic arthritis: A randomized, multicentre, placebo-controlled study
    Combe, B
    Goupille, P
    Kuntz, JL
    Tebib, J
    Liote, F
    Bregeon, C
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 (07): : 664 - 668
  • [7] Abatacept in combination with methotrexate in Japanese biologic-naive patients with active rheumatoid arthritis: a randomised placebo-controlled phase IV study
    Matsubara, Tsukasa
    Inoue, Hiroshi
    Nakajima, Toshihiro
    Tanimura, Kazuhide
    Sagawa, Akira
    Sato, Yukio
    Osano, Kei
    Nagano, Shuji
    Ueki, Yukitaka
    Hanyu, Tadamasa
    Hashizume, Koichi
    Amano, Norihito
    Tanaka, Yoshiya
    Takeuchi, Tsutomu
    RMD OPEN, 2018, 4 (02):
  • [8] Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
    Deodhar, Atul
    Gottlieb, Alice B.
    Boehncke, Wolf-Henning
    Dong, Bin
    Wang, Yuhua
    Zhuang, Yanli
    Barchuk, William
    Xu, Xie L.
    Hsia, Elizabeth C.
    LANCET, 2018, 391 (10136): : 2213 - 2224
  • [9] Treatment of psoriatic arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor
    Kavanaugh, Arthur
    Mease, Philip J.
    Gomez-Reino, Juan J.
    Adebajo, Adewale O.
    Wollenhaupt, Juergen
    Gladman, Dafna D.
    Lespessailles, Eric
    Hall, Stephen
    Hochfeld, Marla
    Hu, ChiaChi
    Hough, Douglas
    Stevens, Randall M.
    Schett, Georg
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (06) : 1020 - 1026
  • [10] OSKIRA-4: a phase IIb randomised, placebo-controlled study of the efficacy and safety of fostamatinib monotherapy
    Taylor, Peter C.
    Genovese, Mark C.
    Greenwood, Mike
    Ho, Meilien
    Nasonov, Evgeny
    Oemar, Barry
    Stoilov, Rumen
    Vencovsky, Jiri
    Weinblatt, Michael
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (12) : 2123 - 2129